Clinical characteristics following BCR-ABL expression in this model include neutrophilia, leukocytosis, and invasion of myeloid cells into multiple organs, including the liver, lungs, and lymph nodes, thus also conferring a CML-like disease to the mice following BCR-ABL expression. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.